Skip to main content

Table 5 Baseline functional, quality of life (N%) or mean (SD)/median (IQR)

From: Baseline characteristics of people experiencing homelessness with a recent drug overdose in the PHOENIx pilot randomised controlled trial

 

PHOENIx participants

(n = 128)

Frailty criteria h

 

 Weight loss

67 (65%)

 Exhaustion

92 (77.3%)

 Low activity

88 (69.8%)

 Slowness

75 (66.4%)

 Weakness

28 (25.2%)

  Positive for frailty phenotype

50 (70.4%)

  Pre-frail

20 (28.2%)

Quality of life (EQ5D5L)b

 

 Mobility

3 (1–4)

(1 = no problem; 2 = slight; 3 = moderate; 4 = severe; 5 = unable to mobilise)

 

 Self-care

2 (1–3)

(1 = no problem; 2 = slight; 3 = moderate; 4 = severe; 5 = unable to self-care)

 

 Usual activities

3 (1–4)

(1 = no problem; 2 = slight; 3 = moderate; 4 = severe; 5 = unable to do usual activities)

 

 Pain/discomfort

3 (2–4)

(1 = no problem; 2 = slight; 3 = moderate; 4 = severe; 5 = extreme pain/discomfort)

 

Anxiety/depression

4 (3–5)

(1 = no problem; 2 = slight; 3 = moderate; 4 = severe; 5 = extreme)

 

 Overall health number—Visual Analogue Scale (VAS)c

34.4 (23.9)

(0 = worst health imaginable; 100 = best health imaginable)

 

 Index Score—crosswalk method to UK Value Set

0.2 (0.3)

(− 0.5 = lowest score on all five domains; 1 = highest score on all five domains)

 

Mealsc1

 

 Breakfast, lunch and dinner

35 (28.5%)

 One meal only per day

34 (27.6%)

 Two meals only per day

34 (27.6%)

 No daily meals

20 (16.3%)

Modified Medical Research Council breathlessness scaled1

2 (1–3)d

Oxygen saturation (%)g

96.4% (2.3%)

Peak expiratory flow rate (% predicted, l/min)i

70.6 (21.5)

Systolic blood pressure (mmHg)e

115.8 (18.5)

Heart rate (beats per minute)f

78.3 (14.0)

Sodium (133–146 mmol/l)k

103 (95.4%)

 Mean (SD)

138.5 (3.2)

Potassium (3.5–5.3 mmol/l)l

104 (95.4)

 Mean (SD)

4.2 (0.5)

Creatinine (40–130umol/l)m

108 (99.1%)

 Mean (SD)

68.4 (15.1)

Estimated GFR (% > 60 ml/min)m

106 (97.2%)

Alanine aminotransferase (% < 50 U/L)n

86 (80.4%)

 Mean (SD)

30.9 (28.6)

Asparate aminotransferase (% < 40 U/L)0

80 (75.5%)

 Mean (SD)

40.2 (40.7)

Alkaline phosphatase (< 130 U/L)0

89 (84.0%)

 Mean (SD)

103.9 (56.1)

Albumin (> 35 g/l)m

63 (57.8%)

 Mean (SD)

36.5 (5.6)

Calcium (adj 2.2–2.6)t

77 (89.5%)

 Mean (SD)

2.3 (0.1)

Magnesium (> 0.7 mmol/l)p

52 (81.2%)

 Mean (SD)

0.8 (0.2)

C-reactive protein (< 10 mg/l)q

53 (51.5%)

 Mean (SD)

19.4 (28.7)

B12 (200–883 ng/l)r

20 (90.9%)

 Mean (SD)

508.3 (217.4)

Folate (serum: 3.1–20.0 ng/ml)s

11 (47.6%)

 Mean (SD)

4.3 (2.4)

Red cell count (4.5–6.5)u

33 (31.1%)

 Mean (SD)

2.3 (0.1)

Platelets (150–410)u

96 (90.6%)

 Mean (SD)

258 (85.6)

  1. Data missing bn = 5; cn = 3. c1n = 5. d, e, f, g, h and i collected at interview. k through to s: collected from clinical records most recent in past year. d1 Options 0 (breathless only on hard exercise-1-2-3-4 (too breathless to leave accommodation). hFrieds frailty phenotype (adapted): ≥ 3 criteria = positive; 1 or 2 criteria = intermediate or pre-frail. d“Walk slower than other people of same age or stop for breath when walking at own pace” data missing n = 13; Data missing en = 5; fn = 4; gn = 3; hn = 57; Imissing data n = 12; Data missing kn = 20; l, mn = 19; nn = 21; on = 22; pn = 64; qn = 25; rn = 106; sn = 108; tn = 42; un = 22